- Investing Ideas
- /
- Materials Healthcare Sector
Materials Healthcare Sector
Results
2309
All the companies in the healthcare sector, including healthcare provider and equipment, healthcare tech, pharmaceuticals, biotech and life sciences.
2,309 companies
Grey Wolf Animal Health
Market Cap: CA$31.8m
Operates as an animal health and wellness company in Canada.
WOLF
CA$0.93
7D
3.3%
1Y
14.8%
ImmunoPrecise Antibodies
Market Cap: US$22.6m
Operates as a techbio company.
IPA
US$0.49
7D
10.2%
1Y
-58.1%
OSR Holdings
Market Cap: US$22.6m
A healthcare holding company, develops a portfolio of therapies and healthcare solutions in the United States, Switzerland, and South Korea.
OSRH
US$1.17
7D
-6.4%
1Y
-89.2%
CurveBeam AI
Market Cap: AU$35.1m
Engages in the development and manufacture of point-of care specialized weight bearing medical imaging equipment in Europe and North America.
CVB
AU$0.09
7D
-14.3%
1Y
-47.1%
Nanalysis Scientific
Market Cap: CA$31.1m
Develops, manufactures, and sells magnetic resonance technology products in Canada, the United States, Europe, Asia, and internationally.
NSCI
CA$0.28
7D
5.8%
1Y
-38.9%
ImmuPharma
Market Cap: UK£16.8m
A biopharmaceutical company, discovers and develops peptide-based therapeutics in the United Kingdom.
IMM
UK£0.034
7D
7.4%
1Y
39.5%
Lisata Therapeutics
Market Cap: US$22.1m
A clinical-stage pharmaceutical company, engages in the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases.
LSTA
US$2.63
7D
25.2%
1Y
-5.1%
Vor Biopharma
Market Cap: US$22.1m
Operates as a clinical-stage cell and genome engineering company.
VOR
US$0.18
7D
16.9%
1Y
-90.2%
NanoViricides
Market Cap: US$22.1m
A clinical stage nano-biopharmaceutical company, discovers, develops, and commercializes drugs for the treatment of viral infections.
NNVC
US$1.41
7D
6.8%
1Y
-31.9%
Scilex Holding
Market Cap: US$22.0m
Focuses on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain.
SCLX
US$4.21
7D
5.0%
1Y
-86.6%
Nexalin Technology
Market Cap: US$21.8m
A medical device company, designs and develops neurostimulation products for the treatment of mental health in the United States and China.
NXL
US$1.27
7D
0%
1Y
-3.1%
Q32 Bio
Market Cap: US$21.6m
A clinical-stage biotechnology company, develops novel biologics to restore healthy immune balance in patients with autoimmune and inflammatory diseases driven by pathological immune dysfunction.
QTTB
US$1.77
7D
14.2%
1Y
-94.2%
Retractable Technologies
Market Cap: US$21.6m
Designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally.
RVP
US$0.72
7D
-4.1%
1Y
-29.4%
Ovid Therapeutics
Market Cap: US$21.5m
A biopharmaceutical company, engages in the development of impactful medicines for patients and families with epilepsies and seizure-related neurological disorders in the United States.
OVID
US$0.30
7D
4.4%
1Y
-90.4%
Rani Therapeutics Holdings
Market Cap: US$21.5m
Operates as a clinical stage biotherapeutics company, focusing on technologies to enable the administration of biologics and drugs orally for patients, physicians, and healthcare systems with a alternative to painful injections in the United States.
RANI
US$0.64
7D
-12.2%
1Y
-87.7%
Little Green Pharma
Market Cap: AU$33.4m
Engages in the cultivation, production, and distribution of medicinal cannabis products in Australia and internationally.
LGP
AU$0.11
7D
-4.3%
1Y
-12.0%
Lipocine
Market Cap: US$21.3m
A clinical-stage biopharmaceutical company, engages in the research and development for the delivery of drugs for the treatment of central nervous system (CNS) disorders.
LPCN
US$3.99
7D
21.8%
1Y
-33.9%
Finch Therapeutics Group
Market Cap: US$21.3m
A clinical-stage microbiome therapeutics company, develops a novel class of orally administered biological drugs in the United States.
FNCH
US$13.26
7D
-1.8%
1Y
583.5%
Oncotelic Therapeutics
Market Cap: US$21.3m
A clinical-stage biopharmaceutical company, engages in the development of drugs for the treatment of orphan oncology indications.
OTLC
US$0.052
7D
-11.2%
1Y
37.1%
Curis
Market Cap: US$21.2m
A biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States.
CRIS
US$2.03
7D
7.4%
1Y
-82.8%
Longeveron
Market Cap: US$21.2m
A clinical stage biotechnology company, develops cellular therapies for aging-related and life-threatening conditions in the United States.
LGVN
US$1.42
7D
6.0%
1Y
10.9%
1CM
Market Cap: CA$29.4m
Operates as a multi-jurisdictional cannabis company in Canada.
EPIC
CA$0.25
7D
0%
1Y
-73.7%
QT Imaging Holdings
Market Cap: US$21.0m
Engages in the research, development, and commercialization of body imaging systems with low frequency sound waves for detection, diagnosis, monitoring, and treatment of diseases in the United States and Internationally.
QTIH
US$0.76
7D
-11.6%
1Y
-14.6%
Sol-Gel Technologies
Market Cap: US$20.8m
Together with its subsidiary Sol-Gel Technologies Inc., develops topical dermatological drugs for patients with severe skin conditions in Israel.
SLGL
US$7.47
7D
-4.8%
1Y
-0.4%
Arecor Therapeutics
Market Cap: UK£15.5m
A clinical stage biotechnology company, develops innovative medicines that address significant unmet patient needs in the United Kingdom.
AREC
UK£0.41
7D
6.5%
1Y
-68.7%
Cambridge Cognition Holdings
Market Cap: UK£15.4m
A neuroscience technology company, develops and markets near-patient cognitive testing techniques in the United States, United Kingdom, the European Union, and internationally.
COG
UK£0.37
7D
0%
1Y
-17.8%
LakeShore Biopharma
Market Cap: US$20.4m
A biopharmaceutical company, engages in the discovering, developing, manufacturing, commercializing, and sale of vaccines and therapeutic biologics for infectious diseases and cancer.
LSB
US$1.07
7D
-6.1%
1Y
-89.1%
Clever Culture Systems
Market Cap: AU$31.8m
Engages in the research, development, and commercialization of technology solutions for medical industry in Australia, the United States, Sweden, the United Kingdom, and Germany.
CC5
AU$0.018
7D
5.9%
1Y
12.5%
PAVmed
Market Cap: US$20.2m
Engages in acquiring, developing, and commercializing novel products that target unmet needs in the United States.
PAVM
US$0.65
7D
-4.8%
1Y
-63.7%
Cognition Therapeutics
Market Cap: US$20.2m
A clinical-stage biopharmaceutical company, engages in the discovery and development of small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina.
CGTX
US$0.33
7D
8.0%
1Y
-83.4%
Woodbrook Group Holdings
Market Cap: US$19.9m
Provides investment and strategic planning advisory services.
WDBG
US$0.06
7D
0%
1Y
100.0%
CollPlant Biotechnologies
Market Cap: US$19.8m
A regenerative and aesthetic medicine company, focuses on three-dimensional (3D) bioprinting of tissues and organs, and medical aesthetics in the United States, Canada, Israel, Europe, and internationally.
CLGN
US$1.73
7D
-4.9%
1Y
-72.7%
Eastwood Bio-Medical Canada
Market Cap: CA$27.6m
Eastwood Bio-Medical Canada Inc. markets and distributes natural health products under the Eleotin brand in Canada, the United States, and Asia.
EBM
CA$0.40
7D
-16.7%
1Y
-27.3%
Lexaria Bioscience
Market Cap: US$19.7m
Operates as a biotechnology company.
LEXX
US$1.01
7D
-6.5%
1Y
-67.9%
Stella Diagnostics
Market Cap: US$19.7m
A research diagnostics company, engages in developing molecular diagnostics tools and new drug targets for esophageal diseases.
SLDX
US$0.049
7D
0%
1Y
n/a
Apimeds Pharmaceuticals US
Market Cap: US$19.7m
Operates as a clinical stage biopharmaceutical company in the United States.
APUS
US$1.70
7D
-22.7%
1Y
n/a